{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:55:40Z","timestamp":1792526140057,"version":"4.5.0"},"reference-count":76,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T00:00:00Z","timestamp":1573344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["212203\/Z\/18\/Z"],"award-info":[{"award-number":["212203\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>This white paper presents principles for validating proarrhythmia risk prediction models for regulatory use as discussed at the <jats:italic>In Silico<\/jats:italic> Breakout Session of a Cardiac Safety Research Consortium\/Health and Environmental Sciences Institute\/US Food and Drug Administration\u2013sponsored Think Tank Meeting on May 22, 2018. The meeting was convened to evaluate the progress in the development of a new cardiac safety paradigm, the Comprehensive <jats:italic>in Vitro<\/jats:italic> Proarrhythmia Assay (CiPA). The opinions regarding these principles reflect the collective views of those who participated in the discussion of this topic both at and after the breakout session. Although primarily discussed in the context of <jats:italic>in silico<\/jats:italic> models, these principles describe the interface between experimental input and model\u2010based interpretation and are intended to be general enough to be applied to other types of nonclinical models for proarrhythmia assessment. This document was developed with the intention of providing a foundation for more consistency and harmonization in developing and validating different models for proarrhythmia risk prediction using the example of the CiPA paradigm.<\/jats:p>","DOI":"10.1002\/cpt.1647","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T04:26:10Z","timestamp":1573446370000},"page":"102-111","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA <i>In Silico<\/i> Strategy"],"prefix":"10.1111","volume":"107","author":[{"given":"Zhihua","family":"Li","sequence":"first","affiliation":[{"name":"Division of Applied Regulatory Science Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Mirams","sequence":"additional","affiliation":[{"name":"Centre for Mathematical Medicine &amp; Biology School of Mathematical Sciences University of Nottingham Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshinaga","sequence":"additional","affiliation":[{"name":"Global Cardiovascular Assessment Eisai Co., Ltd. Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Ridder","sequence":"additional","affiliation":[{"name":"Division of Applied Regulatory Science Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Applied Regulatory Science Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janell E.","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Biometrics VI Office of Biostatistics Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman L.","family":"Stockbridge","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular and Renal Products Office of Drug Evaluation I Office of New Drugs Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Wisialowski","sequence":"additional","affiliation":[{"name":"Global Safety Pharmacology Pfizer, Inc. Groton Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Damiano","sequence":"additional","affiliation":[{"name":"Global Safety Pharmacology\/Nonclinical Safety Janssen Research &amp; Development Raritan New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Severi","sequence":"additional","affiliation":[{"name":"Department of Electrical, Electronic, and Information Engineering University of Bologna Cesena Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Morissette","sequence":"additional","affiliation":[{"name":"Department of Safety Assessment and Laboratory Animal Resources Merck &amp; Co. Kenilworth New Jersey USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[{"name":"Main Line Health and Sidney Kimmel Medical College Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Holbrook","sequence":"additional","affiliation":[{"name":"Certara, Ltd. Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey","family":"Smith","sequence":"additional","affiliation":[{"name":"Clyde Biosciences Ltd Glasgow UK"},{"name":"Institute of Cardiovascular and Medical Sciences Glasgow University Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall L.","family":"Rasmusson","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Cardiology Department of Medicine University of California, Los Angeles Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Cardiology Department of Medicine University of California, Los Angeles Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Qu","sequence":"additional","affiliation":[{"name":"Division of Cardiology Department of Medicine University of California, Los Angeles Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Leishman","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Pathology Eli Lilly and Company Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Steidl\u2010Nichols","sequence":"additional","affiliation":[{"name":"Covance Inc. Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Computer Science University of Oxford Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Bueno\u2010Orovio","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of California Davis Davis California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Victor Chang Cardiac Research Institute Darlinghurst New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Passini","sequence":"additional","affiliation":[{"name":"Department of Computer Science University of Oxford Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of California Davis Davis California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Morotti","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of California Davis Davis California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of California Davis Davis California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Grandi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of California Davis Davis California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen E.","family":"Clancy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology University of California Davis Davis California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Vandenberg","sequence":"additional","affiliation":[{"name":"Victor Chang Cardiac Research Institute Darlinghurst New South Wales Australia"},{"name":"St Vincent's Clinical School UNSW Sydney Darlinghurst New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Hill","sequence":"additional","affiliation":[{"name":"Victor Chang Cardiac Research Institute Darlinghurst New South Wales Australia"},{"name":"St Vincent's Clinical School UNSW Sydney Darlinghurst New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department Chugai Pharmaceutical Co., Ltd. Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Singer","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development Pharmaceutical Sciences Roche Innovation Center Basel F. Hoffmann\u2010La Roche Ltd. Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila","family":"Polonchuk","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development Pharmaceutical Sciences Roche Innovation Center Basel F. Hoffmann\u2010La Roche Ltd. Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Greiter\u2010Wilke","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development Pharmaceutical Sciences Roche Innovation Center Basel F. Hoffmann\u2010La Roche Ltd. Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Wang","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development Pharmaceutical Sciences Roche Innovation Center Basel F. Hoffmann\u2010La Roche Ltd. Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Nave","sequence":"additional","affiliation":[{"name":"Roche Product Development, Safety Science\/Licensing &amp; Early Development F. Hoffmann\u2010La Roche Ltd. Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Fullerton","sequence":"additional","affiliation":[{"name":"Department of Safety Assessment Genentech, Inc. South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Sobie","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Paci","sequence":"additional","affiliation":[{"name":"BioMediTech Faculty of Medicine and Health Technology Tampere University Tampere Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Musuamba Tshinanu","sequence":"additional","affiliation":[{"name":"Federal Agency for Medicines and Health Products Brussels Belgium"},{"name":"European Medicines Agency Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Strauss","sequence":"additional","affiliation":[{"name":"Division of Applied Regulatory Science Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,10]]},"reference":[{"key":"e_1_2_8_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.11.004"},{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2016.06.002"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.896"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.34"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00917"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00616"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004628"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2016.05.005"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1184"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/2168479018795117"},{"key":"e_1_2_8_11_1","unstructured":"Questions & answers: clinical and non\u2010clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential (concept paper): International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use<https:\/\/database.ich.org\/sites\/default\/files\/E14S7B_IWG_Concept_Paper.pdf> (2018)."},{"key":"e_1_2_8_12_1","unstructured":"The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals S7B. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use;2005."},{"key":"e_1_2_8_13_1","unstructured":"The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non\u2010antiarrhythmic drugs E14. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use(2005)."},{"key":"e_1_2_8_14_1","first-page":"269","article-title":"In vitro profiling against ion channels beyond hERG as an early indicator of cardiac risk","volume":"11","author":"Chen M.X.","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2016.12.003"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.02.003"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21606-5"},{"key":"e_1_2_8_18_1","unstructured":"US Food and Drug Administration.Biomarker Qualification: Evidentiary Framework. Guidance for Industry and FDA Staff (Draft)<https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM628118.pdf> (2018)."},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12423"},{"key":"e_1_2_8_20_1","unstructured":"The Report From the Expert Group on (Quantitative) Structure\u2010Activity Relationships on the Principles for the Validation of (Q)SARs(Organization for Economic Co\u2010operation and Development (OECD) Expert Group on QSARs Paris France 2004)."},{"key":"e_1_2_8_21_1","unstructured":"Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7(R1).International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)(2017)."},{"key":"e_1_2_8_22_1","unstructured":"V&V40.Assessing credibility of computational modeling and simulation results through verification and validation: application to medical devices<https:\/\/cstools.asme.org\/csconnect\/FileUpload.cfm?View=yes&ID=42553>American Society of Mechanical Engineers \u2010V&V40 Subcommittee on Verification and Validation of Computational Modeling for Medical Devices(2018)."},{"key":"e_1_2_8_23_1","volume-title":"QTdrugs List","author":"Woosley R.L."},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2010.08.008"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2016.01.008"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1113\/JP271282"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00846-5"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706894"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr044"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706070"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep02100"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.367"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4534"},{"key":"e_1_2_8_34_1","unstructured":"US Food and Drug Administration.Benefit\u2010risk assessment in drug regulatory decision\u2010making. Draft PDUFA VI Implementation Plan (FY 2018\u20132022)<https:\/\/www.fda.gov\/downloads\/ForIndustry\/UserFees\/PrescriptionDrugUserFee\/UCM602885.pdf> (2018)."},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7201.7a"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.09.027"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10439-013-0833-3"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00709"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00668"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(13)71486-5"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2018.12.004"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1039\/C7TX00141J"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1400142"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2018.10.003"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4352"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00816"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167348"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.08.079"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.10.010"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2004.06.003"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2013.04.007"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/15376510902777194"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.117.111534"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.118.115220"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.007765"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00958"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2015.12.002"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2018.06.002"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304382110"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2016.09.011"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.01059"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113583"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.07.026"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.9945.1"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1113\/JP271671"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002061"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1080\/15376516.2016.1256460"},{"key":"e_1_2_8_68_1","volume-title":"Guidance Document on the Validation of (Quantitative) Structure\u2010Activity Relationship [(Q)SAR] Models","year":"2007"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/15401420490426981"},{"key":"e_1_2_8_70_1","doi-asserted-by":"crossref","unstructured":"Parikh J. Di Achielle P. Kozloski J.&Gurev V.Intrinsic structure of model-derived metrics for in silico proarrhytmic risk assessment identified by global sensitivity analysis. 543926 (2019).https:\/\/doi.org\/10.1101\/543926","DOI":"10.1101\/543926"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2008.10.056"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2015.01.008"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfx236"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2015.11.018"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139423"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2011.05.023"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.1647","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.1647","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.1647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:36:45Z","timestamp":1699364205000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.1647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,10]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1002\/cpt.1647"],"URL":"https:\/\/doi.org\/10.1002\/cpt.1647","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,10]]},"assertion":[{"value":"2019-06-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}